Source: Annual Congress 2010 - Infection, inflammation and destruction



Rating:

Share or cite this content

Citations should be made in the following way:
J. Soens, P. Goeminne, L. Dupont, F. De Keyzer, W. De Wever (Belgium). Inter-observer variability in CT evaluation of effect of azithromycin therapy in non-cystic fibrosis bronchiectatic patients. Eur Respir J 2010; 36: Suppl. 54, 4115

Member's Comments

No comment yet.

Related content which might interest you: Retrospective analysis of CT before and after azithromycin therapy in non-cystic fibrosis bronchiectasis using a modified Brody-score Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Free-breathing MRI for monitoring ventilation changes following antibiotic treatment of pulmonary exacerbations in paediatric cystic fibrosis Source: Eur Respir J, 57 (4) 2003104; 10.1183/13993003.03104-2020 Year: 2021 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Physical activity evaluation in non-cystic fibrosis bronchiectasis patients Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017 The effect of maintenance azithromycin on radiological features in patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Evaluation of bone strength by quantitative ultrasound in children with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 339s Year: 2002 Applicative value of chest HRCT for bronchiectasis evaluating in pulmonary infection with pseudomonas aeruginosa in patients with cystic fibrosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Longitudinal structural changes using MDCT in patients with combined pulmonary fibrosis with emphysema Source: Virtual Congress 2021 – Imaging Year: 2021 Voxelwise lung pattern transition scores on HRCT images and their association with symptoms in patients with idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Comparison of emphysema in patients with COPD before and after treatment of tiotropium by quantitative assessment by HRCT Source: Eur Respir J 2007; 30: Suppl. 51, 619s Year: 2007 Comparison of high resolution computerized tomography (HRCT) of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis (CF) patients Source: Eur Respir J 2004; 24: Suppl. 48, 387s Year: 2004 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007 Usefulness of long term treatment with azithromycin in patients with bronchiectasis (non cystic fibrosis) Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Relationship between the radiological pattern in the HRCT and Pneumocystis jirovecii colonization in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 18FDG-PET imaging detects inflammatory changes in pediatric cystic fibrosis patients after treatment for a pulmonary exacerbation Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 The role of lung ultrasonography in the assessment of idiopathic pulmonary fibrosis –correlation with HRCT finding Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019